Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 116

    1.

    Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue.

    Jendle J, Nauck MA, Matthews DR, Frid A, Hermansen K, Düring M, Zdravkovic M, Strauss BJ, Garber AJ; LEAD-2 and LEAD-3 Study Groups.

    Diabetes Obes Metab. 2009 Dec;11(12):1163-72.PMID: 19930006 [PubMed - in process]Related articles

    2.

    Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapy.

    Garber AJ.

    Diabetes Care. 2009 Nov;32 Suppl 2:S184-8. No abstract available. PMID: 19875549 [PubMed - in process]Related articles

    3.

    Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.

    Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schwartz SS.

    Endocr Pract. 2009 Sep-Oct;15(6):540-59.PMID: 19858063 [PubMed - in process]Related articlesFree article

    4.

    Insulin intensification strategies in type 2 diabetes: when one injection is no longer sufficient.

    Garber AJ.

    Diabetes Obes Metab. 2009 Nov;11 Suppl 5:14-8. No abstract available. PMID: 19817779 [PubMed - in process]Related articles

    5.

    The importance of titrating starting insulin regimens in patients with type 2 diabetes.

    Garber AJ.

    Diabetes Obes Metab. 2009 Nov;11 Suppl 5:10-3. No abstract available. PMID: 19817778 [PubMed - in process]Related articles

    6.

    Restaging insulin therapy for patients with type 2 diabetes.

    Garber AJ.

    Diabetes Obes Metab. 2009 Nov;11 Suppl 5:1-5. No abstract available. PMID: 19817776 [PubMed - in process]Related articles

    7.

    What is the best treatment for prediabetes?

    Sharma MD, Garber AJ.

    Curr Diab Rep. 2009 Oct;9(5):335-41.PMID: 19793502 [PubMed - in process]Related articles

    8.

    The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone.

    DeFronzo RA, Hissa MN, Garber AJ, Luiz Gross J, Yuyan Duan R, Ravichandran S, Chen RS; Saxagliptin 014 Study Group.

    Diabetes Care. 2009 Sep;32(9):1649-55. Epub 2009 May 28.PMID: 19478198 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists.

    Garber AJ, Handelsman Y, Einhorn D, Bergman DA, Bloomgarden ZT, Fonseca V, Garvey WT, Gavin JR 3rd, Grunberger G, Horton ES, Jellinger PS, Jones KL, Lebovitz H, Levy P, McGuire DK, Moghissi ES, Nesto RW.

    Endocr Pract. 2008 Oct;14(7):933-46. No abstract available. PMID: 18996826 [PubMed - indexed for MEDLINE]Related articles

    10.

    An overview of incretin clinical trials.

    Garber AJ, Spann SJ.

    J Fam Pract. 2008 Sep;57(9 Suppl):S10-8. Review.PMID: 18786339 [PubMed - indexed for MEDLINE]Related articles

    11.

    Role of insulin signaling in maintaining energy homeostasis.

    Sharma MD, Garber AJ, Farmer JA.

    Endocr Pract. 2008 Apr;14(3):373-80. Review.PMID: 18463047 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea.

    Garber AJ, Foley JE, Banerji MA, Ebeling P, Gudbjörnsdottir S, Camisasca RP, Couturier A, Baron MA.

    Diabetes Obes Metab. 2008 Nov;10(11):1047-56. Epub 2008 Feb 18.PMID: 18284434 [PubMed - indexed for MEDLINE]Related articles

    13.

    Update: vildagliptin for the treatment of Type 2 diabetes.

    Garber AJ, Sharma MD.

    Expert Opin Investig Drugs. 2008 Jan;17(1):105-13. Review.PMID: 18095923 [PubMed - indexed for MEDLINE]Related articles

    14.

    Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials.

    Garber AJ, Clauson P, Pedersen CB, Kølendorf K.

    J Am Geriatr Soc. 2007 Nov;55(11):1735-40.PMID: 17979896 [PubMed - indexed for MEDLINE]Related articles

    15.

    Reducing the risk of stroke through appropriate targets and treatments.

    Davidson MH, Basile J, Garber AJ, Phillips RA.

    Prev Cardiol. 2007 Fall;10(4):215-21.PMID: 17917519 [PubMed - indexed for MEDLINE]Related articles

    16.

    Premixed insulin treatment for type 2 diabetes: analogue or human?

    Garber AJ, Ligthelm R, Christiansen JS, Liebl A.

    Diabetes Obes Metab. 2007 Sep;9(5):630-9. Review.PMID: 17697056 [PubMed - indexed for MEDLINE]Related articles

    17.

    Diabetic dyslipidemia and the heart.

    Vasudevan AR, Garber AJ.

    Heart Fail Clin. 2006 Jan;2(1):37-52. Review. No abstract available. PMID: 17386875 [PubMed - indexed for MEDLINE]Related articles

    18.

    Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study.

    Garber AJ, Schweizer A, Baron MA, Rochotte E, Dejager S.

    Diabetes Obes Metab. 2007 Mar;9(2):166-74.PMID: 17300592 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.

    Bosi E, Camisasca RP, Collober C, Rochotte E, Garber AJ.

    Diabetes Care. 2007 Apr;30(4):890-5. Epub 2007 Feb 2.PMID: 17277036 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Basal insulin or premix analogue therapy in type 2 diabetes patients.

    Raskin PR, Hollander PA, Lewin A, Gabbay RA, Bode B, Garber AJ; on behalf of the INITIATE Study Group.

    Eur J Intern Med. 2007 Jan;18(1):56-62.PMID: 17223044 [PubMed - in process]Related articles

    21.

    Assessing the role of biphasic insulin aspart 30 as an effective and tolerable front-line therapy for type 2 diabetes.

    Garber AJ.

    Clin Ther. 2005;27 Suppl B:S39-41. No abstract available. PMID: 16519036 [PubMed - indexed for MEDLINE]Related articles

    22.

    New standards to reduce morbidity and mortality in hospitalized patients with diabetes.

    Garber AJ.

    Am Fam Physician. 2006 Feb 15;73(4):591, 594. No abstract available. PMID: 16506704 [PubMed - indexed for MEDLINE]Related articles

    23.

    Premixed insulin analogues for the treatment of diabetes mellitus.

    Garber AJ.

    Drugs. 2006;66(1):31-49. Review.PMID: 16398567 [PubMed - indexed for MEDLINE]Related articles

    24.

    The metabolic syndrome: a call to action.

    Gotto AM Jr, Blackburn GL, Dailey GE 3rd, Garber AJ, Grundy SM, Sobel BE, Weir MR.

    Coron Artery Dis. 2006 Feb;17(1):77-80. Review.PMID: 16374146 [PubMed - indexed for MEDLINE]Related articles

    25.

    Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

    Garber AJ, Wahlen J, Wahl T, Bressler P, Braceras R, Allen E, Jain R.

    Diabetes Obes Metab. 2006 Jan;8(1):58-66.PMID: 16367883 [PubMed - indexed for MEDLINE]Related articles

    26.

    Pharmacologic modifications of hormones to improve their therapeutic potential for diabetes management.

    Garber AJ.

    Diabetes Obes Metab. 2005 Nov;7(6):666-74. Review.PMID: 16219010 [PubMed - indexed for MEDLINE]Related articles

    27.

    Insulin resistance syndrome. A review.

    Vasudevan AR, Garber AJ.

    Minerva Endocrinol. 2005 Sep;30(3):101-19. Review.PMID: 16208303 [PubMed - indexed for MEDLINE]Related articles

    28.

    Cardiovascular risk and diabetes mellitus management: diagnosis and treatment in special patient populations. Introduction.

    Garber AJ.

    Am J Med. 2005 Apr;118 Suppl 2:1S-2S. No abstract available. PMID: 15903288 [PubMed - indexed for MEDLINE]Related articles

    29.

    Point: Inpatient glucose management: the emperor finally has clothes.

    Bryer-Ash M, Garber AJ.

    Diabetes Care. 2005 Apr;28(4):973-5. Review. No abstract available. PMID: 15793209 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    The metabolic syndrome.

    Garber AJ.

    Med Clin North Am. 2004 Jul;88(4):837-46, ix. Review.PMID: 15308381 [PubMed - indexed for MEDLINE]Related articles

    31.

    New advances in insulin treatment of diabetes: overcoming barriers.

    Davidson JA, Garber AJ, DiMarchi RD, Santiago JV.

    Endocr Pract. 1997 Nov-Dec;3(6):371-84.PMID: 15251776 [PubMed]Related articles

    33.

    Effect of premixed nph and regular insulin on glucose control and health-related quality of life in patients with type 2 diabetes mellitus.

    Davidson JA, Einhorn D, Allweiss P, Flood TM, Garber AJ, Garcia MJ, Kahn CB, Soler NG, White Jr JR, Huster WJ.

    Endocr Pract. 1997 Nov-Dec;3(6):331-6.PMID: 15251769 [PubMed]Related articles

    34.

    Diabetes and atherosclerosis: mechanisms and management.

    Horvit PK, Garber AJ.

    Endocr Pract. 1998 Mar-Apr;4(2):112-9.PMID: 15251756 [PubMed]Related articles

    35.

    Current standards of care for inpatient glycemic management and metabolic control: is it time for definite standards and targets?

    Garber AJ, Seidel J, Armbruster M.

    Endocr Pract. 2004 Mar-Apr;10 Suppl 2:10-2.PMID: 15251634 [PubMed - indexed for MEDLINE]Related articles

    36.

    American College of Endocrinology position statement on inpatient diabetes and metabolic control.

    Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V; American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control.

    Endocr Pract. 2004 Mar-Apr;10 Suppl 2:4-9. No abstract available. PMID: 15251633 [PubMed - indexed for MEDLINE]Related articles

    37.

    American College of Endocrinology position statement on inpatient diabetes and metabolic control.

    Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V; American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control.

    Endocr Pract. 2004 Jan-Feb;10(1):77-82. No abstract available. PMID: 15251626 [PubMed - indexed for MEDLINE]Related articles

    38.

    Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center.

    Goss JA, Goodpastor SE, Brunicardi FC, Barth MH, Soltes GD, Garber AJ, Hamilton DJ, Alejandro R, Ricordi C.

    Transplantation. 2004 Feb 15;77(3):462-6.PMID: 14966428 [PubMed - indexed for MEDLINE]Related articles

    39.

    Metformin and vascular protection: a diabetologist's view.

    Garber AJ.

    Diabetes Metab. 2003 Sep;29(4 Pt 2):6S113-6. Review.PMID: 14502108 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.

    Garber AJ, Donovan DS Jr, Dandona P, Bruce S, Park JS.

    J Clin Endocrinol Metab. 2003 Aug;88(8):3598-604.PMID: 12915642 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Benefits of combination therapy of insulin and oral hypoglycemic agents.

    Garber AJ.

    Arch Intern Med. 2003 Aug 11-25;163(15):1781-2. No abstract available. PMID: 12912710 [PubMed - indexed for MEDLINE]Related articles

    42.

    Cardiovascular complications of diabetes: prevention and management.

    Garber AJ.

    Clin Cornerstone. 2003;5(2):22-37. Review.PMID: 12800478 [PubMed - indexed for MEDLINE]Related articles

    43.

    Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.

    Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C.

    Transplantation. 2002 Dec 27;74(12):1761-6.PMID: 12499894 [PubMed - indexed for MEDLINE]Related articles

    45.

    Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats.

    Lee HJ, Choi SS, Park MK, An YJ, Seo SY, Kim MC, Hong SH, Hwang TH, Kang DY, Garber AJ, Kim DK.

    Biochem Biophys Res Commun. 2002 Aug 16;296(2):293-9.PMID: 12163016 [PubMed - indexed for MEDLINE]Related articles

    46.

    Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes.

    Garber AJ, Larsen J, Schneider SH, Piper BA, Henry D; Glyburide/Metformin Initial Therapy Study Group.

    Diabetes Obes Metab. 2002 May;4(3):201-8. Erratum in: Diabetes Obes Metab. 2002 Jul;4(4):286.. PMID: 12047399 [PubMed - indexed for MEDLINE]Related articles

    47.

    Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice.

    Garber AJ.

    Diabetes Obes Metab. 2002 Jan;4 Suppl 1:S5-12. Review.PMID: 11843949 [PubMed - indexed for MEDLINE]Related articles

    48.

    Meta-analysis of studies using selective alpha1-blockers in patients with hypertension and type 2 diabetes.

    Glanz M, Garber AJ, Mancia G, Levenstein M.

    Int J Clin Pract. 2001 Dec;55(10):694-701.PMID: 11777296 [PubMed - indexed for MEDLINE]Related articles

    49.

    Treatment of dyslipidemia in diabetes.

    Garber AJ, Karlsson FO.

    Endocrinol Metab Clin North Am. 2001 Dec;30(4):999-1010. Review.PMID: 11727408 [PubMed - indexed for MEDLINE]Related articles

    50.

    Implications of cardiovascular risk in patients with type 2 diabetes who have abnormal lipid profiles: is lower enough?

    Garber AJ.

    Diabetes Obes Metab. 2000 Oct;2(5):263-70. Review.PMID: 11225741 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...